TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $368 | +76.9% | 44,065 | +425.5% | 0.00% | – |
| Q2 2023 | $208 | -80.4% | 8,385 | -88.1% | 0.00% | -100.0% |
| Q1 2023 | $1,062 | -67.4% | 70,670 | -74.4% | 0.00% | -75.0% |
| Q4 2022 | $3,262 | -99.6% | 275,784 | +117.1% | 0.00% | +300.0% |
| Q3 2022 | $752,000 | +10.4% | 127,028 | -20.8% | 0.00% | 0.0% |
| Q2 2022 | $681,000 | -56.0% | 160,409 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $1,549,000 | -28.2% | 162,899 | +43.4% | 0.00% | -50.0% |
| Q4 2021 | $2,158,000 | +57.2% | 113,598 | +234.6% | 0.00% | +100.0% |
| Q3 2021 | $1,373,000 | -4.2% | 33,947 | -8.1% | 0.00% | 0.0% |
| Q2 2021 | $1,433,000 | – | 36,947 | +350.4% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 8,204 | -9.6% | 0.00% | -100.0% |
| Q4 2020 | $472,000 | -62.3% | 9,076 | -80.6% | 0.00% | -50.0% |
| Q3 2020 | $1,252,000 | +190.5% | 46,821 | +111.5% | 0.00% | +100.0% |
| Q2 2020 | $431,000 | +606.6% | 22,134 | +253.7% | 0.00% | – |
| Q1 2020 | $61,000 | -91.3% | 6,257 | -90.1% | 0.00% | -100.0% |
| Q4 2019 | $700,000 | +373.0% | 63,099 | +138.2% | 0.00% | – |
| Q3 2019 | $148,000 | -29.5% | 26,493 | +1.3% | 0.00% | -100.0% |
| Q1 2019 | $210,000 | +36.4% | 26,146 | -30.6% | 0.00% | – |
| Q4 2018 | $154,000 | -79.4% | 37,658 | -34.0% | 0.00% | -100.0% |
| Q2 2018 | $749,000 | +101.9% | 57,018 | +25.7% | 0.00% | -81.2% |
| Q4 2017 | $371,000 | -43.4% | 45,348 | -18.0% | 0.02% | -40.7% |
| Q3 2017 | $655,000 | +214.9% | 55,301 | +166.3% | 0.03% | +200.0% |
| Q2 2017 | $208,000 | -83.8% | 20,766 | -81.2% | 0.01% | -83.9% |
| Q1 2017 | $1,286,000 | +5258.3% | 110,390 | +3373.6% | 0.06% | +2700.0% |
| Q3 2016 | $24,000 | +84.6% | 3,178 | +47.8% | 0.00% | +100.0% |
| Q2 2016 | $13,000 | -58.1% | 2,150 | -42.6% | 0.00% | -50.0% |
| Q1 2016 | $31,000 | -71.8% | 3,743 | -59.6% | 0.00% | -77.8% |
| Q4 2015 | $110,000 | +423.8% | 9,260 | +326.3% | 0.01% | +350.0% |
| Q3 2015 | $21,000 | -84.9% | 2,172 | -75.3% | 0.00% | -88.2% |
| Q4 2014 | $139,000 | – | 8,776 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |